Acute Critical Care
ClearMate™ is intended for immediate carbon monoxide poisoning treatment.
Intended Patient Population
Minimum of 16 years old and a minimum of 40 kg (80.8 lbs)
ClearMate™ is intended to be used by:
- Emergency department medical professionals at a hospital
- ClearMate™ should only be used by emergency department medical professionals at a hospital.
- ClearMate™ should always be used as adjunctive therapy; not intended to replace existing protocol for treating carbon monoxide poisoning.
Potential Side Effects
ClearMate™ induces hyperventilation and administers oxygen and carbon dioxide gas. Use of ClearMate™ Smay produce shortness of breath, sweating, nausea, and headache.
ClearMate™ is a medical device intended for use only by or under the order of a physician.